Neuphoria Therapeutics Inc.
NEUP
Hisse Senetlerindeki Sıralama
#29127
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Hisse Fiyatı
$3.92
Son senkronizasyon: 2026-07-31
Piyasa Değeri
$21.16M
Değişim (1 gün)
-0.13%
Değişim (1 yıl)
60,767.52%
Ülke
US
Ticaret Neuphoria Therapeutics Inc. (NEUP)
Kategori
Healthcare
Neuphoria Therapeutics Inc. (NEUP) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.01 - 2023-08-01
Gün sonu en düşük fiyat: $0.56 - 1999-12-01
Gün sonu en düşük fiyat: $0.56 - 1999-12-01
Neuphoria Therapeutics Inc. için hisse fiyatı geçmişi: 1999 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2023 | -78.35% |
| 2022 | -97.66% |
| 2021 | 1,363.12% |
| 2020 | 63.69% |
| 2019 | -30.83% |
| 2018 | -71.66% |
| 2017 | 18.70% |
| 2016 | -12.16% |
| 2015 | -19.29% |
| 2014 | -47.97% |
| 2013 | 95.06% |
| 2012 | -36.40% |
| 2011 | -90.46% |
| 2010 | 1,655.11% |
| 2009 | 133.43% |
| 2008 | -61.74% |
| 2007 | 121.34% |
| 2006 | 1.97% |
| 2005 | -16.73% |
| 2004 | -11.05% |
| 2003 | -22.47% |
| 2002 | -28.01% |
| 2001 | -20.19% |
| 2000 | -11.88% |
| 1999 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
